Green Thumb Sees Canaccord Raise Price Target Following Earnings Beat

On August 11th, Green Thumb Industries Inc. (CSE: GTII) released its second quarter financial results. The company announced revenues of $221.9 million, up 14.1% sequentially. The company had adjusted EBITDA of $79.3 million and a net income of $22.1 million. The company had a gross profit of $122.9 million, up 10.9%.

Only one analyst raised their 12-month price target on the company, bringing the average consensus up to $59.03 from $57.92 last month. The company has 16 analysts covering the stock with 4 having strong buy ratings and the other 12 have buy ratings. The street high sits at $77 from BTIG while the lowest target comes in at $45.

Canaccord Genuity was the only firm to raise their 12-month price target on Green Thumb, raising it to $56 from $54, while reiterating their buy rating on the stock saying that these results came in better than expected. They also add that three acquisitions that closed after the quarter ended will help Green Thumb going into the next quarter.

Green Thumb beat every one of Canaccord’s estimates. Canaccord estimated revenue to come in at $213.73 million, Gross margins of $121.82 million, adjusted EBITDA to be $77.14 million, and a net income of $11.59 million. The key drivers to the beat were Illinois and Pennsylvania sales coming in sequentially higher while same-store sales grew 7%. For the segments, CPG grew 13% while retail grew 15%.

Below you can see Canaccord’s updated 2021 and 2022 estimates.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

This Gold Story Starts With Cash Flow | Gordon Robb – ESGold

Silverco Cusi Mine PEA: Bigger Isn’t Always Better

Fixing Heart Disease Tied to Sudden Death in Young People | David Elsley – Cardiol Therapeutics

Recommended

Cambria Drills 17.95 g/t Gold Over 22 Metres At Premier Mine

Denarius Metals Increases Bid For Emerita Resources To $0.45 Per Share

Related News

Cresco Labs: Stifel Raises Price Target To $21.50 Following Bluma Acquisition

Yesterday morning, it was announced that Cresco Labs (CSE: CL) is entering Florida with its...

Friday, January 15, 2021, 11:53:00 AM

Haywood: TPCO Is “A Formidable California Cannabis Company with Unparalleled Consumer Reach”

Just two weeks after the de-SPACing of TPCO Holdings Corp (NEO: GRAM.u) (OTC: GRAMF), which...

Friday, January 29, 2021, 04:03:00 PM

Plug Power: BMO Raises Price Target To $41 On Revised Guidance

On November 9th, Plug Power (NASDAQ: PLUG) reported its third quarter financial results. The company...

Friday, November 12, 2021, 05:03:00 PM

Cresco Labs: Stifel Slashes Price Target From $30 To $8 Following Poor Q4 Results

On March 23rd, Cresco Labs (CSE: CL) announced its fourth-quarter financial results, which disappointed many...

Friday, March 25, 2022, 03:39:00 PM

Southwest Airlines: Analyst Consensus Estimates For Q1 2021

Southwest Airlines (NASDAQ: LUV) will be reporting their first quarter results on April 22nd before...

Tuesday, April 20, 2021, 11:49:00 AM